ARCHIVES

NSABP Accrual Slow, But Auditing Called “Impressive”

This article is from The Cancer Letter archive.

Vol. 21 No. 03 | January 20, 1995

Download PDF Visit The Full Archive

Related Articles

Seven New Initiatives For NIH Common Fund

February 26, 2010

M.D. Anderson Sells Itself As Research Base For CCOPs

August 8, 1986

NTP Panel Agrees PBB Carcinogenic, Two Asbestos Varieties Are Not

July 3, 1981

NCI Bypass Budget Calls For $5.98 Billion

December 6, 2002

Top Officials Resign From San Antonio’s Institute for Drug Development.

January 26, 2007

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

May 9, 2003